Guardant Health (NASDAQ: GH) reported Q4 EPS of ($0.62), $0.16 better than the analyst estimate of ($0.78). Revenue for the quarter came in at $201.8 million versus the consensus estimate of $186.78 million.

GUIDANCE:

Guardant Health sees FY2025 revenue of $850-860 million, versus the consensus of $850.3 million.

For earnings history and earnings-related data on Guardant Health (GH) click here.